Gastalo Phil medicine for hyperconemia in acute and chronic liver disease (10 blisters x 10 tablets)
Dosage form Box of 10 blisters x 10 tablets
Specifications L-Ornithine-L-ASPARTATE
Ingredient
| Composition information | Content |
| L-Ornithine-L-ASPARTATE | 500mg |
Uses
Indications
L-Ornithin L- aspartat 500mg is indicated in the following cases:
A few clinical trials with effective reporting of blood ammonia reduces blood ammonia by increasing urea synthesis. However, there are still many unanimous views on the hypotension effect of L-Ornithin L-Aspartat.
L-Ornithin-L-Aspartat stimulates the process of detoxifying ammonia by increasing the synthesis of urea in the urea cycle, in addition it also eliminates the liver ammonia from the tissues, thus detoxifying and protecting liver cells.
In addition, L-Ornithin-L-Aspartat also produces energy in the form of ATP, thereby improving the energy balance of the liver.pharmacokinetics
l-Ornithin-l-zaSpartat provides two important substrates for both Urea and Glutamine synthesis. After oral, L-Ornithin-L-Aspartat dissociated into l-ornithin and L-Aspartic acid, two substances that were then absorbed in the small intestine by active transportation through the brush brush of the small intestine epithelium, that absorption depends on the level of sodium ion concentration. Oral bioavailability of L-Ornithin-L-Aspartat is 82.2 ± 28%. Ornithine can go through the bloody barrier.
Before taking Gastalo Phil medicine for hyperconemia in acute and chronic liver disease (10 blisters x 10 tablets)
How to use
Oral drugs.
Dosage
Adults:
1 - 3 capsules x 3 times daily, after eating, for 1-2 weeks. Maintain: 1 tablet x 3 times daily for 4-5 weeks depending on the doctor's instructions.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose? Using more drugs will not improve your symptoms; Instead they can cause poisoning or serious side effects. If you suspect that you or anyone else may have overdosed of L-Ornithin L-aspartat 500mg, please go to the emergency room at the nearest hospital or hospital. Bring a box, shell, or pharmacy with you to help doctors have the necessary information.
Do not give your medicine to others even though you know they have the same disease or look like they may have the same disease. This can lead to overdose.
So far, there has been no reporting on the overdose of L-Ornithin L-aspartat 500mg.
Please consult your doctor or pharmacist or product package for more information.
What to do when you forget the dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.
Side Effects
When using L-Ornithin L-aspartat 500mg, you may experience unwanted effects (ADR).
Some side effects recorded in research on users of this drug are:
Instructions on how to handle ADR
If you encounter any unwanted effect, stop taking the medication and immediately notify your doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
L-Ornithin L-aspartat 500mg contraindicated in the following cases:
Be cautious when taking the drug
Before using L-Ornithin L-aspartat 500mg, you should note the following:
Notify the doctor and pharmacist if you are allergic to Losartan, any other drug or any ingredients in the drug. You can also ask the pharmacist for a list of ingredients.
Do not use the drug when the drug expires or has a change in smell or color.
Children, the elderly, pregnant and lactating women.
The ability to drive and operate machinery
The drug has almost no effect on driving and operating machinery. However, there are also a few reports on the risk of dizziness, so the doctor may depend on the specific case that is recommended or not recommended for patients to use drugs when driving and operating machinery.
Pregnancy
The safety of the drug in pregnant women has not been determined. If necessary, you should consult your doctor, pharmacist to consider benefits and risks.
Breastfeeding period
The safety of the drug in breastfeeding women has not been determined. If necessary, you should consult a doctor and pharmacist to consider the benefits of the mother and the risk of the child.
Other special subjects (elderly, children, allergies).
No report.
Medicinal interaction
Medicinal interaction can change the ability of the drug or increase the effects of side effects. It is best to write a list of drugs you are taking (including prescription, non -prescription and functional foods) and for doctors or pharmacists. Do not arbitrarily take the drug, stop or change the dosage of the drug without the permission of a doctor.
There is no report on drug interaction.
Please consult your doctor about taking medicine with food, alcohol and tobacco.
Your health status may affect the use of this drug. Tell your doctor if you have any health problems.
Storage
You should store at room temperature, avoid moisture and avoid light. No storage in the bathroom or in the freezer. You should remember that each drug may have different storage methods. Therefore, you should read carefully storage instructions on the packaging or ask the pharmacist. Keep pills out of reach of children and pets.
Expiry date: 36 months from the date of manufacture.
Other drugs
- ANTEPSIN 1G/5ML ORAL SUSPENSION / SUCRALFATE 1G/5ML ORAL SUSPENSION
- Avamys
- BEZALIP RETARD TABLETS 400MG
- SERACTIL 400MG FILM-COATED TABLETS
- SURGICAL SPIRIT BP
- UTOVLAN
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions